Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHill's Opaganib Compared to Matched Case-Control Group

Stock Information for Redhill Biopharma Ltd.

Loading

Please wait while we load your information from QuoteMedia.